The Company’s principal shareholders and their percentage interests in the capital of Laboratorios Farmacéuticos ROVI are as follows:

Name % Total (A) % Direct % Indirect
ALANTRA ASSET MANAGMENT SGIIC S.A. 5,020 0,000 5,020
INDUMENTA PUERI, S.L. 5,000 5,000 0,000
J O HAMBRO CAPITAL MANAGEMENT LIMITED 5,460 0,000 5,469
NORBEL INVERSIONES, S.L. 69,640 69,640 0,000
QMC II IBERIAN CAPITAL FUND, FIL 4,400 4,400 0,000
T. ROWE PRICE ASSOCIATES INC. 3,005 0,000 3,005